Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RN7SL664P** (RNA, 7SL, cytoplasmic 664, pseudogene) is classified as a pseudogene resembling 7SL RNA, a component of the signal recognition particle (SRP) complex which is essential for targeting proteins to the endoplasmic reticulum in eukaryotes[1][3][5][6]. The majority of 7SL-like sequences in the human genome are not functional genes but pseudogenes: non-coding remnants that do not produce functional RNA or protein and arise from reverse transcription of parent 7SL RNA molecules followed by integration into the genome[5][6]. RN7SL664P does not encode a protein, does not have any known biological function, and is not known to play a role in normal physiology or disease[1][5][6]. There are hundreds of such 7SL pseudogenes in the human genome, and while some pseudogenes may acquire regulatory or pathological activity in rare cases, there is currently no evidence for such a role for RN7SL664P in any disease or as a biomarker[1][5][6]. It is not a therapeutic target, and there are no known drug interactions, mechanisms of action, safety concerns, or established biomarker roles for this sequence.\n\n**Summary points:**\n- RN7SL664P is a non-coding pseudogene, not a therapeutic target[1][5][6].\n- It is not associated with disease, drug action, or diagnostic utility.\n- It is an inactive genetic element with no current known biological significance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 664, pseudogene (RN7SL664P).